Suchen Sie nach Informationen zu Hauptsitz Von Eurand Nv? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Eurand NV - Company Profile and News - Bloomberg …

    https://www.bloomberg.com/profile/company/EURX:US
    Company profile page for Eurand NV including stock price, company news, press releases, executives, board members, and contact information

Eurand - Crunchbase Company Profile & Funding

    https://www.crunchbase.com/organization/eurand
    Company Type For Profit. Phone Number (800) 678-1605. Eurand N.V. (Eurand) is a holding company. The Company is a specialty pharmaceutical company that develops, manufactures and commercializes pharmaceutical and biopharmaceutical products. The Company is commercializing a portfolio of products for cystic fibrosis (CF) and gastrointestinal (GI) …

Eurand N.V. Sample Contracts | Law Insider

    https://www.lawinsider.com/company/1119745/eurand-n-v
    Eurand N.V. – INDEMNIFICATION AGREEMENT This Indemnification Agreement, dated as of , 2007 is made by and between Eurand, N.V., a public company with limited liability, organized and existing under the laws of the Netherlands (the “Company”), EA Acquisitions Corp., a Delaware corporation and wholly owned subsidiary of the Company (the “Guarantor”) and (the …

Eurand Pharmaceuticals, Inc. Company Profile | Yardley, …

    https://www.dnb.com/business-directory/company-profiles.eurand_pharmaceuticals_inc.acaa08af809b837729ee1f62dd1c11b8.html
    Find company research, competitor information, contact details & financial data for Eurand Pharmaceuticals, Inc. of Yardley, PA. Get the latest business insights from Dun & Bradstreet.

EURAND N.V. : Press releases | NL0000886448 | MarketScreener

    https://www.marketscreener.com/quote/stock/EURAND-N-V-50679/news-communiques/
    EURAND N.V. : Press releases relating to EURAND N.V. Investor relations | Nasdaq: | Nasdaq

EURAND NV financials 2022 | EURX - Macroaxis

    https://www.macroaxis.com/financials/EURX/EURAND-NV
    Understanding current and past EURAND NV Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of EURAND NV's financial statements are interrelated, with each one affecting the others. For example, an increase in EURAND NV's assets may result in an increase in income on the …

Who owns Eurand Nv? Top stakeholders of Eurand Nv according …

    https://stockzoa.com/cusip/296421993/
    To download the data without a subscription, you can purchase 90-day access to Eurand Nv position data for $28.00 USD (one time). Email address. Full name. Credit or debit card .

What is EURAND NV Valuation? (NASDAQ:EURX) - Macroaxis

    https://www.macroaxis.com/valuation/EURX/EURAND-NV
    EURAND NV prevailing Real Value cannot be determined due to lack of data. The current price of EURAND NV is USD0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time.Macroaxis commonly computes value of EURAND NV from evaluating the firm technical indicators and Probability Of Bankruptcy.In general, we advise acquiring undervalued …

Eurand N.V. Stock-

    https://www.sharewise.com/us/instruments/Eurand_Nv
    Eurand N.V. Change: %, current price: € Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer.

EURAND AKTIEN News - A0MSPK Nachrichten

    https://www.finanznachrichten.de/nachrichten-aktien/eurand-nv.htm
    EURAND NV WKN: A0MSPK ISIN: NL0000886448 Ticker-Symbol: N/A ... Die US-Regierung hat im großen Stil weiteren Corona-Impfstoff von Pfizer und Biontech für eine geplante Booster-Kampagne im Herbst ...

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Eurand Nv gefunden haben.